Overview

• Colossal reports it has cultured primordial germ cells from the Nicobar pigeon, a key advance for avian programs because birds cannot be cloned.
• The workflow involves injecting those pigeon germ cells into genetically modified chickens to act as surrogates, followed by CRISPR edits to recreate dodo‑like traits.
• Executives project first births in roughly five to seven years and target large cohorts with engineered genetic diversity rather than a few individuals.
• Plans for reintroduction are being developed with the Mauritian Wildlife Foundation, with emphasis on predator‑controlled sites and suitable habitat on Mauritius.
• An additional $120 million financing lift brings a reported valuation near $10.2 billion, as experts question authenticity and warn of ecological and ethical risks.